Detalhe da pesquisa
1.
Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.
Leukemia
; 32(2): 383-390, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28761118
2.
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.
Leukemia
; 31(11): 2398-2406, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28804124
3.
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.
Leukemia
; 30(3): 562-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26464170
4.
Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma.
Leukemia
; 29(8): 1721-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25787915